Christopher Russo

Christopher Russo currently serves as a Senior Research Associate at Arbor Biotechnologies, focusing on the development of programmable DNA editors for curative genetic medicines. Previously, Christopher held senior research associate positions at Skyhawk Therapeutics and Fulcrum Therapeutics, where efforts were directed at addressing genetically defined diseases and advancing drug discovery. Prior experiences include a role as a Senior Research Associate at Foundation Medicine, specializing in genomic profiling assays for cancer, and research technologist positions at Massachusetts General Hospital, contributing to studies on movement disorders and genetic research. Christopher Russo is pursuing a Master of Arts in Biotechnology at Harvard Extension School, having earned a Bachelor of Science in Biobehavioral Health from Penn State University.